Fourteen patients with Borrelia burgdorferi infection were investigated for possible abnormalities of tryptophan and neopterin metabolism. Four patients (2 were investigated before therapy, 2 when therapy had been already started) had acute Lyme neuroborreliosis, and 10 patients were investigated months to years after an acute infection. Increased concentrations of neopterin and of the tryptophan-degradation product, ,-kynurenine, were detected in the cerebrospinal fluid of patients with acute Lyme neuroborreliosis; one patient presented with subnormal tryptophan. Similar but less marked changes were seen in the treated patients and in some of the patients with Lyme encephalopathy. No such abnormalities were seen in the serum of the patients. The data indicate a role of the immune System and particulary of endogenously formed cytokines, like interferon-and tumour necrosis factor-a, effecting tryptophan and neopterin metabolism in patients with acute Lyme neuroborreliosis.
Introduction
The tick-borne spirochaete, Borrelia burgdorferi, is the aetiological agent of Lyme borreliosis, a disease, which may also affect the nervous System. In the acute disseminated phase, meningitis, cranial neuritis and radiculoneuritis represent a typical triad of clinical manifestation. These Symptoms respond rapidly to antibiotic therapy (1). Whether ongoing infection or öther mechanisms cause chronic neurologic manifestations after adequate antibiotic therapy is still unclear.
Specific T-and B-dymphocyte respönses'have been demonstrated in humans (2) after infection with B, burgdorferi. Increased neopterin and Z^kynurenine concentrations in the cerebrospinal flüid of patients with Lyme neuroborreliosis have been described recently (3, 4) . These data indicate a eellular immune response and intrathecal release of interferon-in patients. Interferonstrongly induces activation of GTP cyclohydrolase I and formation of neopterin in human monocytes/macrophages (5) . Likewise, indoleamine (2,3)-dioxygenase is stimulated by interferon-in human monocytes/macrophages and in a variety of other cells and cell lines (6) (7) (8) . The induction of GTP cyclohydrolase I and indoleamine (2,3)-dioxygenase by interferon-is enhanced by tumour necrosis factor-a (8) .
In the present study, we compared tryptophan metabolism (i. e. changes in tryptophan and kynurenine concentrations) with neopterin levels in 4 patients with acute neuroborreliosis and in 10 patients months to years after the acute stage of the illness.
Patients and Methods

Patients
Fourteen serum and 13 cerebrospinal fluid samples were investigated from 4 patients with acute neuroborreliosis and 10 patients months to years after the acute stage of the illness. The patients (cJ/$ ratio 6/8, median age 61, ränge 28-70 years at time of sample collection) were diagnosed and treated between 1983 and 1992 at the Neurological Department, University of Innsbruck. Samples were taken trom acute infection patients l and 2 before the commencement of antibiotic therapy, and from acute infection patients 3 and 4 after the commencement of antibiotic therapy (tab. l). Ten patients were investigated months to years (median 41, ränge 11 -106 months) after antibiotic therapy. These patients were part of an earlier evaluation of 20 patients with Lyme encephalopathy (9), who agreed io a spinal tap for cerebrospinal fluid collection. In one of these patients a spinal tap was not possible because of massive degenerative vertebral changes.
Concentrations of analytes were compared with normal ranges from earlier studies (tab. 2). As an additional control, serum from 20 healthy blood donors, 19-61 years of age, was included, because serum tryptophan and kynurenine coneentrations in an earlier study (10) were obtained with a slightly different high-performance liquid Chromatographie method.
Methods
Samples were stored at -20 °C until measurement. Neopterin coneentrations were quantified by radioimmunoassay (IMMUtest Neopterin, Henning-Berlin, Berlin, Germany). Tryptophan and Lkynurenine concentrations were quantified using high-performance liquid chromatography with on-line deproteinization of serum and cerebrospinal fluid samples (10, 11) . Separation was performed on reversed phase C18 material (LiChroCart, Merck, Darmstadt, Germany) injecting 100 μΐ of sample via an advanced autosampling device (AASP, Varian, Palo Alto, California) using solid-phase extraction on cartridges (SCX, Varian) before liquid chromatography (10) . Kynurenine was monitored by its ultraviolet absorption at 360 nm, tryptophan by fluorescence detection at 365 nm emission and 285 nm excitation wavelengths. The limits of detection were 0. l μηιοΐ/ΐ kynurenine (signal/noise ratio of 5/1), 0.2 μπιοΙ/1 tryptophan (signal/noise ratio of 5/1) and 3 nmol/1 neopterin.
For statistical evaluation we used non-parametric methods, namely the Mann-Wtiitney U-test for comparison between groups and the Spearman rank correlation analyses to analyse associations between analyte concentrations.
Results
In the diagnosis of Lyme neuroborreliosis, eight of the 14 patients showed the typical triad of neurological manifestations -meningitis, cranial ne ritis (seven unior bilateral facial nerve palsy, one bilateral hypoacusis) and radiculoneuritis, four suffered froin meningitis and radiculoneuritis, one from meningitis and cranial ne ritis (right abducens paralysis) and one from cranial ne ritis (bilateral abducens paralysis and hypoacusis, right facial nerve palsy) without meningitis. Six patients had a history of erythema migrans. Cerebrospinal fluid investigations displayed lymphocytic-predominant pleocytosis in 13 patients (median cell counts 110, r nge 8-357 X 10 6 /1) and elevated protein (median 1.29, r nge 0.70-5.58 g/l) in 12 of 13 patients. In nine patients intrathecal B. burgdorferi antibody production and/or B. burgdorferi specific oligoclonal antibodies were determined; one showed no sign of intrathecal antibody production (tab. 1). In this case neuroborreliosis was clinically diagnosed (typical triad of neurologic manifestations, arthralgias and immediate recovery after antibiotic treatment). In five patients, the ratio of intrathecal B. burgdorferi-specific antibody production versus serurn titres was not determined: on case with radiculoneuritis and lyniphocytic meningitis and a B. burgdorferi IgG-titre in cerebrospinal fluid > l : 256 (immunofluorescence test), one case with lymphocytic meningitis, radiculitic pain, bilateral facial palsy and positive B. burgdorferi serum IgG-titre (l : 256) and IgM-titre (l : 64) one year after onset of clinical Symptoms (at first misdiagnosed s meningeal tuberculosis), one case with cranial ne ritis Without menigitis, serum IgG-titre l : 64 and IgM-titre l : 128, two cases with meningitis and radiculoneuritis and positive IgG in cerebrospinal fluid (l case ELISA, l immunofluorescence test; titre was not determined). Overall durati of neurologic manifestations varied according to the time of diagnosis and treatment. Mean duration of irivolvement was 5 weeks (3 to 9 weeks); however, five patients had a much longer acute stage (3 to 12 months, mean 7.8 months). Nine patients (see from 1990 to 1992) were treated with 2 g ceftriaxone for 14 days, f ur (seen from 1983 to 1987) received iiitravenous penicillin, 20 million units a day in a devided dose for ten days, arid one was treated with tetracyclin, 2000 mg a day, after developing an allergic reaction to penicillin.
At the time of sample collection for this evaluation, cerebrospinal fluid investigations of the four patients with acute illness (two before, two after onset of antibiotic treatment) displayed a lymphocytic pleocytosis and protein elevation (mean cell counts 86, r nge 25-245 X 10 6 /1; mean protein 0.87, r nge 0.52-1.22 g/l). Eight of nine cerebrospinal fluid investigations out of the Lyme encephalopathy group were normal, and one showed a mild protein elevation (0.59 g/l). CHnie l f llow-up of these ten patients revealed residual Symptoms in four cases (rnild right facial nerve palsy, mild radicular Symptoms, mild radicular Symptoms and right facial nerve palsy, bilateral abducens paralysis and hypoacusis).
In 20 healthy controls, serum concentrations of neopterin (mean ± S. D.: 5.2 ± 1.79 nmol/1), tryptophan (89.2 ± 15.6 μπιοΐ/ΐ) and kynurenine (2.1 ± 0.49 μπιοΙ/1) agreed well with the normal r nge found in earlier studies which, however, was determined with a slighly different high-performance liquid chromatography method. The kynurenine : tryptophan ratio was 24.4 ± 7.4.
In patients with acute Lyme neuroborreliosis a coincidental increase of the neopterin and kynurenine concentrations was observed, which was pronounced in eerebrospinal fluid but not iii the serum of patients. All patients with acute Lyme neuroborreliosis and most patients with late Lyme encephalbpatby had normal serum concentrations of neopterin (elevated in 2/10 patients in the latter group) and kynurenine (elevated in 1/9 patients in the latter group; tab. 2). Tryptophan concentrations in serum were below normal ia 2/4 patients with acute Lyrne neuroborreliosis (bothMintreated patients) and in Neopterin was higher in patients (n = 14: 7.4 ± 2.2 nmol/l) than in the controls (n = 20: 5.2 ± 1.8 nmol/l; U = 3.13, p = 0.0017). Interestingly, a correlation existed between serum and cerebrospinal fluid tryptophan concentrations (rs = 0.714, p = 0.043) in the s bgroup of patients with late Lyme erteephalopathy. Cerebrospinal fluid concentrations of neopterin (U = 2.10; p < 0.05) and kynurenine (U = 2.11; p < 0.05) were higher in patients with acute Lyme neuroborreliosis compared with those with late Lyme encephalopathy, where s tryptophan concentrations did not differ. In serum, no differences were found between patients with acute Lyme neuroborreliosis and patients with late Lyme encephalopathy.
Discussion
The data confirm and extend earlief results obtained in patients with B. burdorferi infection (3, 4) and are consistent with the view that degradation of tryptophan due to immune activation was the reason for the accumulation of L-kynurenine. Increased concentrations of neopterin in cerebrospinal fluid indicate activation of immunocompetent cells in the brain and indirectly confirm the endogenous formation of cytokines, such s interferon-γ and tumour necrosis factor-α, in the patients, because large ampunts of neopterin are released from human monocytes/macrophages upon activation with in* terferon-γ in vitro. Our data also demonstrate that significant degradation of tryptophan occurs in the cerebrospinal fluid of patients with acute Lyme neuroborreliosis. Thus, the increase of the tryptophan metabolite, kynurenine, correlates with the increase of neopterin. Importantly, kynurenine was even higher in patient 3, who had an extremely low tryptophan concentration in the cerebrospinal fluid (tab. 2). This observation can be explained by the strong activation of indoleamine (2,3)-dioxygenase, s indicated by the very high kynurenine : tryptophan ratio of 2000 in the same patient. Interestingly, similar associations between the formation of neopterin and kynurenine have also been demonstrated in patients suffering from multiple sclerosis (13) . Changes of tryptophan metabolism possibly play role in the pathogenesis of neurological Symptoms in patients. On the one hand, a decrease of tryptophan may disturb serotonin metabolism (4); on the other hand neurotoxic products of tryptophan degradation, like kynurenic acid or quinolinic acid, may have a role (14) . One of our patients showed a severely decreased tryptophan level in cerebrospinal fluid, and serum tryptophan levels tended to decrease in several patients of bothgroups, even when there was no detectable increase of tryptophan metabolites in serum. It appears that, in the chronic Situation, degradation of tryptophan in. cerebro-spinal fhiid may also contribute to the deficiency of tryptophan in serum by causing a compensatory flux of tryptophan into the brain. Interestingly, a significant association between serum and cerebrospinal fluid tryptophan levels was found in the patients with late Lyme encephalopathy (rs = 0.714, p = 0.05).
When comparing late Lyme encephalopathy with acute Lyme neuroborreliosis, it is evident that metabolic changes in cerebrospinal fluid are much more pronounced in the latter group of patients. However, similar correlations existed between the changes of tryptophan metabolism and neopterin in late Lyme encephalopathy, which suggests a low-level, on-going infection, at least in some patients. This would lead to low-grade chronic immune activation, with increased degradation of tryptophan. In our patients with late Lyme encephalopathy, however, we found no correlation between biochemical changes and specific clinical Symptoms, such äs chronic neurological manifestations. From this observation, it appears that irreversible damage of brain tissue, particularly during the acute phase of Lyme neuroborreliosis, is the major determinant of late Symptoms in patients. Further studies are needed to clarify this point.
